Project Details
Description
Phase III randomised, placebo-controlled, double-blind, multicentre, clinical trial to determine the efficacy and safety of Presendin in idiopathic intracranial hypertension
Status | Active |
---|---|
Effective start/end date | 2/27/23 → 12/31/24 |
Funding
- INVEX THERAPEUTICS
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.